SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-060065
Filing Date
2024-05-13
Accepted
2024-05-10 19:35:23
Documents
12
Period of Report
2024-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2414196d1_6k.htm 6-K 48399
2 GRAPHIC tm2414196d1_6kimg001.jpg GRAPHIC 223560
3 GRAPHIC tm2414196d1_6kimg002.jpg GRAPHIC 217876
4 GRAPHIC tm2414196d1_6kimg003.jpg GRAPHIC 222203
5 GRAPHIC tm2414196d1_6kimg004.jpg GRAPHIC 260158
6 GRAPHIC tm2414196d1_6kimg005.jpg GRAPHIC 261695
7 GRAPHIC tm2414196d1_6kimg006.jpg GRAPHIC 266042
8 GRAPHIC tm2414196d1_6kimg007.jpg GRAPHIC 282035
9 GRAPHIC tm2414196d1_6kimg008.jpg GRAPHIC 258011
10 GRAPHIC tm2414196d1_6kimg009.jpg GRAPHIC 267892
11 GRAPHIC tm2414196d1_6kimg010.jpg GRAPHIC 235788
12 GRAPHIC tm2414196d1_6kimg011.jpg GRAPHIC 56946
  Complete submission text file 0001104659-24-060065.txt   3566000
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 24936562
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)